935-34 Special Considerations for Diabetics Receiving Platelet IIb/IIIa Antagonists During Coronary Interventions: Results from the EPIC Trialart
- 28 February 1995
- journal article
- abstracts
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 25 (2) , 155A-156A
- https://doi.org/10.1016/0735-1097(95)92099-q
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: